Cost-of-illness analysis of ulcerative colitis patients treated with biological therapy: a prospective observational study in Iran.

ABSTRACT:

Background

No research has assessed the comprehensive annual costs of managing ulcerative colitis (UC) patients undergoing biological treatment. This study aimed to determine the annual costs and primary cost drivers for UC patients receiving biological therapy.

Methods

This prospective observational study was conducted in Iran from a societal perspective, employing the cost-of-illness method, grounded in human capital theory. A prevalence-based approach and bottom-up technique were used for cost estimation. Inpatient costs were extracted from hospital records, while outpatient service usage and direct non-medical costs over a one-year follow-up were collected through patient interviews. Indirect costs were evaluated using a standardized questionnaire. The average costs per

SUBMITTER: Karami H 

PROVIDER: S-EPMC11884057 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature